Login / Signup

Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas.

Samantha OttaviKelin LiJackson G CacioppoAndrew J PerkowskiRemya RameshBen S GoldYan LingJulia RobertsAmrita SinghDavid ZhangJohn MosiorLaurent GoullieuxChristine RoubertEric BacquéJames C SacchettiniCarl F NathanJeffrey Aube
Published in: ACS medicinal chemistry letters (2023)
4'-Phosphopantetheinyl transferase (PptT) is an essential enzyme for Mycobacterium tuberculosis ( Mtb ) survival and virulence and therefore an attractive target for a tuberculosis therapeutic. In this work, two modeling-informed approaches toward the isosteric replacement of the amidinourea moiety present in the previously reported PptT inhibitor AU 8918 are reported. Although a designed 3,5-diamino imidazole unexpectedly adopted an undesired tautomeric form and was inactive, replacement of the amidinourea moiety afforded a series of active PptT inhibitors containing 2,6-diaminopyridine scaffolds.
Keyphrases